Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.
Autism Therapy Under Scrutiny: Private Equity and Rising Treatment Hours
A closer look at rising autism therapy hours, private equity incentives and Medicaid spending—and why care should be shaped by each child’s needs, goals and family circumstances.



0 Comments